NR1I2 and inflammatory bowel disease: Recent studies have reported that intestinal PXR regulates the expression of NF-κB and may be protect the mice from IBD (Okamura et al., 2020), but it remains to be determined whether LCA or 3-keto-LCA is involved in activation of hepatic and intestinal PXR.